Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sayuka Nakayama
Observed name:
Sayuka NAKAYAMA
Institution:
SHOWA Medical University
Observed institution:
SHOWA Medical University
ORCID:
0000-0002-6443-118X
Observed ORCID:
0000-0002-6443-118X
OpenAlex ID:
A5018615601
BRCAness as a prognostic indicator in patients with early breast cancer
2020
·
Lei Liu
, Yuki Matsunaga
, et al.
·
Scientific Reports
·
32
PDF
Digital volumetric measurement of mammographic density and the risk of overlooking cancer in Japanese women
2017
·
Terumasa Sawada
, Sadako Akashi
, et al.
·
Breast Cancer
·
20
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)
2021
·
Takamichi Yokoe
, Sasagu Kurozumi
, et al.
·
Breast Cancer
·
15
PDF
Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case–control study of abemaciclib-induced interstitial lung disease (NOSIDE)
2024
·
Sayuka Nakayama
, Ayuha Yoshizawa
, et al.
·
Breast Cancer
·
7
Identifying ductal carcinoma in situ cases not requiring surgery to exclude postoperative upgrade to invasive ductal carcinoma
2022
·
Sayuka Nakayama
, Hiroko Masuda
, et al.
·
Breast Cancer
·
6
Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy
2020
·
Makoto Ishitobi
, Naoko Matsuda
, et al.
·
Annals of Surgical Oncology
·
5
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy
2025
·
Sayuka Nakayama
, Takayuki Iwamoto
, et al.
·
Breast Cancer
·
2
Abstract PD7-05: A multicenter prospective study to predict pathologic complete response by vacuum-assisted breast biopsy based on MRI and US findings after neoadjuvant chemotherapy
2022
·
Naoki Hayashi
, Natsuki Teruya
, et al.
·
Cancer Research
·
2
Correction: Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians
2026
·
Hiroko Masuda
, Takaaki Konishi
, et al.
·
Breast Cancer
PDF
Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians
2026
·
Hiroko Masuda
, Takaaki Konishi
, et al.
·
Breast Cancer
Clinicopathological Characterization of HER2-Low-Expressing Triple-Negative Breast Cancer: Distinct Features From HER2-Zero Subtype
2026
·
Michiko Kato
, Hiroko Masuda
, et al.
·
Clinical Breast Cancer
Abstract P4-11-20: Development of a method for detecting genetic mutations in early breast cancer using Plasma-Safe-SeqS technology and its clinical application
2025
·
Reika Yoshida
, Naoki Akiyama
, et al.
·
Clinical Cancer Research
Abstract P5-11-17: Clinicopathological characterized by HER2-low-expressing breast cancer in triple-negative breast cancer
2025
·
Michiko Kato
, Hiroko Masuda
, et al.
·
Clinical Cancer Research
A Case of Recurrent Breast Cancer Undergoing Risk-reducing Salpingo-oophorectomy Owing to Long-term Complete Response to Olaparib
2025
·
Sayuka NAKAYAMA
, Minoru NAGASHIMA
, et al.
·
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
PDF
Retrospective Analysis of the Clinical Usefulness of a Strut-Adjusted Volume Implant in a Single Center
2024
·
Arisa Ata-Shiroshita
, Takashi Kuwayama
, et al.
·
European Journal of Breast Health
PDF
Risk factors of ipsilateral breast tumor recurrence in triple-negative or HER2-positive breast cancer patients who achieved pathological complete response after neoadjuvant chemotherapy.
2020
·
Mizuho Tazo
, Yasuyuki Kojima
, et al.
·
Journal of Clinical Oncology
Real-world study of the treatments following trastuzumab-emtansine for HER2-positive metastatic breast cancer: A multicentral cohort study (WJOG12519B).
2020
·
Sasagu Kurozumi
, Takamichi Yokoe
, et al.
·
Journal of Clinical Oncology
Real-world study of treatments after T-DM1 for HER2-positive metastatic breast cancer (WJOG12519B)
2020
·
Akiko Nishimura
, Takamichi Yokoe
, et al.
·
日本乳癌学会学術総会プログラム・抄録集
Show more works
View as search
Works count:
18
Citation count:
89
H-index:
5
I10-index:
3
Year
Topic
Type